O	0	1	A
O	2	12	randomized
O	13	18	trial
O	19	21	of
O	22	23	a
B-intervention	24	33	telephone
I-intervention	33	34	-
I-intervention	34	43	delivered
I-intervention	44	52	exercise
O	53	65	intervention
O	66	69	for
O	70	73	non
O	73	74	-
O	74	79	urban
O	80	88	dwelling
O	89	94	women
O	95	100	newly
O	101	110	diagnosed
O	111	115	with
O	116	122	breast
O	123	129	cancer
O	129	130	:
O	131	139	exercise
O	140	143	for
O	144	150	health
O	150	151	.

O	152	160	Physical
O	161	169	activity
O	170	172	is
O	173	182	important
O	183	192	following
O	193	199	breast
O	200	206	cancer
O	206	207	.

O	208	214	Trials
O	215	217	of
O	218	221	non
O	221	222	-
O	222	226	face
O	226	227	-
O	227	229	to
O	229	230	-
O	230	234	face
O	235	248	interventions
O	249	252	are
O	253	259	needed
O	260	262	to
O	263	269	assist
O	270	272	in
O	273	281	reaching
O	282	287	women
O	288	294	living
O	295	302	outside
O	303	308	major
O	309	321	metropolitan
O	322	327	areas
O	327	328	.

O	329	333	This
O	334	339	study
O	340	345	seeks
O	346	348	to
O	349	357	evaluate
O	358	361	the
O	362	373	feasibility
O	374	377	and
O	378	391	effectiveness
O	392	394	of
O	395	396	a
O	397	406	telephone
O	406	407	-
O	407	416	delivered
O	416	417	,
O	418	423	mixed
O	424	431	aerobic
O	432	435	and
O	436	446	resistance
O	447	455	exercise
O	456	468	intervention
O	469	472	for
O	473	476	non
O	476	477	-
O	477	482	urban
B-ethinicity	483	493	Australian
B-eligibility	494	499	women
I-eligibility	500	504	with
I-eligibility	505	511	breast
I-eligibility	512	518	cancer
O	518	519	.

O	520	521	A
O	522	532	randomized
O	533	543	controlled
O	544	549	trial
O	550	559	comparing
O	560	562	an
O	563	564	8
O	564	565	-
O	565	570	month
O	571	583	intervention
O	584	593	delivered
O	594	596	by
O	597	605	exercise
O	606	619	physiologists
O	620	621	(
O	621	622	n
O	623	624	=
B-intervention-participants	625	627	73
O	627	628	)
O	629	631	to
B-control	632	637	usual
I-control	638	642	care
O	643	644	(
O	644	645	n
O	646	647	=
B-control-participants	648	650	70
O	650	651	)
O	651	652	.

O	653	658	Sixty
O	658	659	-
O	659	662	one
O	663	670	percent
O	671	682	recruitment
O	683	687	rate
O	688	691	and
O	692	694	96
O	694	695	%
B-outcome	696	705	retention
O	706	708	at
O	709	711	12
O	712	718	months
O	718	719	;
O	720	722	79
O	722	723	%
O	724	726	of
O	727	732	women
O	733	735	in
O	736	739	the
O	740	752	intervention
O	753	758	group
O	759	767	received
O	768	770	at
O	771	776	least
O	777	779	75
O	779	780	%
O	781	783	of
O	784	789	calls
O	789	790	;
O	791	795	odds
O	796	797	(
O	797	799	OR
O	799	800	,
O	801	803	95
O	803	804	%
O	805	807	CI
O	807	808	)
O	809	811	of
B-outcome	812	819	meeting
I-outcome	820	832	intervention
I-outcome	833	840	targets
O	841	848	favored
O	849	852	the
O	853	865	intervention
O	866	871	group
O	872	875	for
O	876	886	resistance
O	887	895	training
O	896	897	(
O	897	899	OR
O	900	901	3
O	901	902	.
O	902	903	2
O	903	904	;
O	905	906	1
O	906	907	.
O	907	908	2
O	908	909	,
O	910	911	8
O	911	912	.
O	912	913	9
O	913	914	)
O	915	918	and
O	919	926	aerobic
O	927	928	(
O	928	930	OR
O	931	932	2
O	932	933	.
O	933	934	1
O	934	935	;
O	936	937	0
O	937	938	.
O	938	939	8
O	939	940	,
O	941	942	5
O	942	943	.
O	943	944	5
O	944	945	)
O	946	954	activity
O	954	955	.

O	956	961	Given
O	962	965	the
O	966	973	limited
O	974	986	availability
O	987	989	of
O	990	998	physical
O	999	1007	activity
O	1008	1016	programs
O	1017	1020	for
O	1021	1024	non
O	1024	1025	-
O	1025	1030	urban
O	1031	1036	women
O	1037	1041	with
O	1042	1048	breast
O	1049	1055	cancer
O	1055	1056	,
O	1057	1064	results
O	1065	1072	provide
O	1073	1079	strong
O	1080	1087	support
O	1088	1091	for
O	1092	1103	feasibility
O	1104	1107	and
O	1108	1114	modest
O	1115	1122	support
O	1123	1126	for
O	1127	1130	the
O	1131	1139	efficacy
O	1140	1142	of
O	1143	1152	telephone
O	1152	1153	-
O	1153	1162	delivered
O	1163	1176	interventions
O	1176	1177	.
